BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 37974079)

  • 1. Distribution of Plasmodium falciparum K13 gene polymorphisms across transmission settings in Ghana.
    Dieng CC; Morrison V; Donu D; Cui L; Amoah L; Afrane Y; Lo E
    BMC Infect Dis; 2023 Nov; 23(1):801. PubMed ID: 37974079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Local emergence in Amazonia of
    Mathieu LC; Cox H; Early AM; Mok S; Lazrek Y; Paquet JC; Ade MP; Lucchi NW; Grant Q; Udhayakumar V; Alexandre JS; Demar M; Ringwald P; Neafsey DE; Fidock DA; Musset L
    Elife; 2020 May; 9():. PubMed ID: 32394893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Artemisinin resistance-associated markers in Plasmodium falciparum parasites from the China-Myanmar border: predicted structural stability of K13 propeller variants detected in a low-prevalence area.
    He Y; Campino S; Diez Benavente E; Warhurst DC; Beshir KB; Lubis I; Gomes AR; Feng J; Jiazhi W; Sun X; Huang F; Tang LH; Sutherland CJ; Clark TG
    PLoS One; 2019; 14(3):e0213686. PubMed ID: 30883571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A review of the frequencies of Plasmodium falciparum Kelch 13 artemisinin resistance mutations in Africa.
    Ndwiga L; Kimenyi KM; Wamae K; Osoti V; Akinyi M; Omedo I; Ishengoma DS; Duah-Quashie N; Andagalu B; Ghansah A; Amambua-Ngwa A; Tukwasibwe S; Tessema SK; Karema C; Djimde AA; Dondorp AM; Raman J; Snow RW; Bejon P; Ochola-Oyier LI
    Int J Parasitol Drugs Drug Resist; 2021 Aug; 16():155-161. PubMed ID: 34146993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No polymorphisms in K13-propeller gene associated with artemisinin resistance in Plasmodium falciparum isolated from Brazzaville, Republic of Congo.
    Mayengue PI; Niama RF; Kouhounina Batsimba D; Malonga-Massanga A; Louzolo I; Loukabou Bongolo NC; Macosso L; Ibara Ottia R; Kimbassa Ngoma G; Dossou-Yovo LR; Pembet Singana B; Ahombo G; Sekangue Obili G; Kobawila SC; Parra HJ
    BMC Infect Dis; 2018 Oct; 18(1):538. PubMed ID: 30373565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of K13 mutations in Plasmodium falciparum persisting after artemisinin combination therapy treatment of Kenyan children.
    Muwanguzi J; Henriques G; Sawa P; Bousema T; Sutherland CJ; Beshir KB
    Malar J; 2016 Jan; 15():36. PubMed ID: 26801909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absence of association between polymorphisms in the K13 gene and the presence of Plasmodium falciparum parasites at day 3 after treatment with artemisinin derivatives in Senegal.
    Madamet M; Kounta MB; Wade KA; Lo G; Diawara S; Fall M; Bercion R; Nakoulima A; Fall KB; Benoit N; Gueye MW; Fall B; Diatta B; Pradines B
    Int J Antimicrob Agents; 2017 Jun; 49(6):754-756. PubMed ID: 28450175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel pfk13 polymorphisms in Plasmodium falciparum population in Ghana.
    Matrevi SA; Tandoh KZ; Bruku S; Opoku-Agyeman P; Adams T; Ennuson NA; Asare B; Hagan OCK; Abuaku B; Koram KA; Fox A; Quashie NB; Letizia AG; Duah-Quashie NO
    Sci Rep; 2022 May; 12(1):7797. PubMed ID: 35551239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Limited polymorphisms in k13 gene in Plasmodium falciparum isolates from Dakar, Senegal in 2012-2013.
    Torrentino-Madamet M; Fall B; Benoit N; Camara C; Amalvict R; Fall M; Dionne P; Ba Fall K; Nakoulima A; Diatta B; Diemé Y; Ménard D; Wade B; Pradines B
    Malar J; 2014 Dec; 13():472. PubMed ID: 25471113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasmodium falciparum Kelch Propeller Polymorphisms in Clinical Isolates from Ghana from 2007 to 2016.
    Matrevi SA; Opoku-Agyeman P; Quashie NB; Bruku S; Abuaku B; Koram KA; Fox A; Letizia A; Duah-Quashie NO
    Antimicrob Agents Chemother; 2019 Nov; 63(11):. PubMed ID: 31427297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphisms of the artemisinin resistant marker (K13) in Plasmodium falciparum parasite populations of Grande Comore Island 10 years after artemisinin combination therapy.
    Huang B; Deng C; Yang T; Xue L; Wang Q; Huang S; Su XZ; Liu Y; Zheng S; Guan Y; Xu Q; Zhou J; Yuan J; Bacar A; Abdallah KS; Attoumane R; Mliva AM; Zhong Y; Lu F; Song J
    Parasit Vectors; 2015 Dec; 8():634. PubMed ID: 26667053
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Stokes BH; Dhingra SK; Rubiano K; Mok S; Straimer J; Gnädig NF; Deni I; Schindler KA; Bath JR; Ward KE; Striepen J; Yeo T; Ross LS; Legrand E; Ariey F; Cunningham CH; Souleymane IM; Gansané A; Nzoumbou-Boko R; Ndayikunda C; Kabanywanyi AM; Uwimana A; Smith SJ; Kolley O; Ndounga M; Warsame M; Leang R; Nosten F; Anderson TJ; Rosenthal PJ; Ménard D; Fidock DA
    Elife; 2021 Jul; 10():. PubMed ID: 34279219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Profiles of Kelch mutations in Plasmodium falciparum across South Asia and their implications for tracking drug resistance.
    Chhibber-Goel J; Sharma A
    Int J Parasitol Drugs Drug Resist; 2019 Dec; 11():49-58. PubMed ID: 31606696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic association between the Pfk13 gene mutation and artemisinin resistance phenotype in Plasmodium falciparum isolates from Yunnan Province, China.
    Dong Y; Wang J; Sun A; Deng Y; Chen M; Xu Y; Xue J
    Malar J; 2018 Dec; 17(1):478. PubMed ID: 30563521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The lack of K13-propeller mutations associated with artemisinin resistance in Plasmodium falciparum in Democratic Republic of Congo (DRC).
    Yobi DM; Kayiba NK; Mvumbi DM; Boreux R; Bontems S; Kabututu PZ; De Mol P; Speybroeck N; Mvumbi GL; Hayette MP
    PLoS One; 2020; 15(8):e0237791. PubMed ID: 32822392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural selection of K13 mutants of Plasmodium falciparum in response to artemisinin combination therapies in Thailand.
    Putaporntip C; Kuamsab N; Kosuwin R; Tantiwattanasub W; Vejakama P; Sueblinvong T; Seethamchai S; Jongwutiwes S; Hughes AL
    Clin Microbiol Infect; 2016 Mar; 22(3):285.e1-8. PubMed ID: 26548510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular insights into artemisinin resistance in Plasmodium falciparum: An updated review.
    Azmi WA; Rizki AFM; Djuardi Y; Artika IM; Siregar JE
    Infect Genet Evol; 2023 Aug; 112():105460. PubMed ID: 37269964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular Surveillance of Artemisinin-Based Combination Therapies Resistance in Plasmodium falciparum Parasites from Bioko Island, Equatorial Guinea.
    Liu Y; Liang X; Li J; Chen J; Huang H; Zheng Y; He J; Ehapo CS; Eyi UM; Yang P; Lin L; Chen W; Sun G; Liu X; Zha G; Wang J; Wang C; Wei H; Lin M
    Microbiol Spectr; 2022 Jun; 10(3):e0041322. PubMed ID: 35670601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absence of association between polymorphisms in the pfcoronin and pfk13 genes and the presence of Plasmodium falciparum parasites after treatment with artemisinin derivatives in Senegal.
    Delandre O; Daffe SM; Gendrot M; Diallo MN; Madamet M; Kounta MB; Diop MN; Bercion R; Sow A; Ngom PM; Lo G; Benoit N; Amalvict R; Fonta I; Mosnier J; Diawara S; Wade KA; Fall M; Fall KB; Fall B; Pradines B
    Int J Antimicrob Agents; 2020 Dec; 56(6):106190. PubMed ID: 33045351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular surveillance of Kelch 13 polymorphisms in Plasmodium falciparum isolates from Kenya and Ethiopia.
    Jeang B; Zhong D; Lee MC; Atieli H; Yewhalaw D; Yan G
    Malar J; 2024 Jan; 23(1):36. PubMed ID: 38287365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.